Publications (27) Publications in which a researcher has participated View referenced research data.

filter_list Microbiology

2014

  1. Comparison of local features from two Spanish hospitals reveals common and specific traits at multiple levels of the molecular epidemiology of metallo-β-lactamase-producing pseudomonas spp

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 4, pp. 2454-2458

  2. Overexpression of MexCD-OprJ reduces pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 4, pp. 2426-2429

  3. The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 9, pp. 5084-5095

2013

  1. A trade-off between oxidative stress resistance and DNA repair plays a role in the evolution of elevated mutation rates in bacteria

    Proceedings of the Royal Society B: Biological Sciences, Vol. 280, Núm. 1757

  2. Biological markers of Pseudomonas aeruginosa epidemic high-risk clones

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 11, pp. 5527-5535

  3. Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 Loop that affects ceftazidime hydrolysis

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 10, pp. 5158-5161

  4. Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli

    Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417

  5. First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 1, pp. 589-591

2012

  1. Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 8, pp. 4540-4543

  2. Extensively drug-resistant Pseudomonas aeruginosa: Risk of bloodstream infection in hospitalized patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 10, pp. 2791-2797

  3. Intrinsic and environmental mutagenesis drive diversification and persistence of pseudomonas aeruginosa in chronic lung infections

    Journal of Infectious Diseases, Vol. 205, Núm. 1, pp. 121-127

  4. Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4′)-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 4, pp. 2139-2142

2011

  1. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 10, pp. 4560-4568

  2. Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM)

    FEMS Microbiology Letters, Vol. 324, Núm. 1, pp. 28-37

  3. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-β-lactamases

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 11, pp. 5376-5379

  4. Evolution and adaptation in pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators

    PLoS ONE, Vol. 6, Núm. 11

  5. Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 7, pp. 3406-3412

2010

  1. Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 9, pp. 3933-3937

  2. Carbapenemasas en especies del género Pseudomonas

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. SUPPL. 1, pp. 19-28

2009

  1. Azithromycin in pseudomonas aeruginosa biofilms: Bactericidal activity and selection of nficB mutants

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 4, pp. 1552-1560